Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.

Kukita A, Kukita T, Nagata K, Teramachi J, Li YJ, Yoshida H, Miyamoto H, Gay S, Pessler F, Shobuike T.

Arthritis Rheum. 2011 Sep;63(9):2744-54. doi: 10.1002/art.30455.

2.

Regulators of osteoclast differentiation and cell-cell fusion.

Miyamoto T.

Keio J Med. 2011;60(4):101-5. Review.

3.

Bone destruction in arthritis.

Gravallese EM.

Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii84-6. Review.

4.

Action of RANKL and OPG for osteoclastogenesis.

Kobayashi Y, Udagawa N, Takahashi N.

Crit Rev Eukaryot Gene Expr. 2009;19(1):61-72. Review.

PMID:
19191757
5.
6.

Promising bone-related therapeutic targets for rheumatoid arthritis.

Choi Y, Arron JR, Townsend MJ.

Nat Rev Rheumatol. 2009 Oct;5(10):543-8. doi: 10.1038/nrrheum.2009.175. Review.

7.

[Bone structure in rheumatoid arthritis].

Ono K, Ohashi S, Tanaka S, Matsumoto T.

Clin Calcium. 2013 Jul;23(7):983-91. doi: CliCa1307983991. Review. Japanese.

PMID:
23811586
8.

Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review.

Nevius E, Gomes AC, Pereira JP.

Clin Rev Allergy Immunol. 2016 Aug;51(1):59-78. doi: 10.1007/s12016-015-8520-9. Review.

9.

Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.

Baum R, Gravallese EM.

Clin Rev Allergy Immunol. 2016 Aug;51(1):1-15. doi: 10.1007/s12016-015-8515-6. Review.

10.

Immunology and bone.

Danks L, Takayanagi H.

J Biochem. 2013 Jul;154(1):29-39. doi: 10.1093/jb/mvt049. Epub 2013 Jun 7. Review.

PMID:
23750028
11.
12.

Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis.

Henriksen K, Bollerslev J, Everts V, Karsdal MA.

Endocr Rev. 2011 Feb;32(1):31-63. doi: 10.1210/er.2010-0006. Epub 2010 Sep 17. Review.

PMID:
20851921
13.

[Osteoclast biology and osteoimmunology].

Nakashima T.

Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(1):17-25. doi: 10.2177/jsci.38.17. Review. Japanese.

14.

[Osteoimmunology-overview].

Okamoto K, Takayanagi H.

Clin Calcium. 2012 Nov;22(11):1641-9. doi: CliCa121116411649. Review. Japanese.

PMID:
23103807
15.

Functional genetic and genomic analysis of modeled arthritis.

Douni E, Armaka M, Kontoyiannis DL, Kollias G.

Adv Exp Med Biol. 2007;602:33-42. Review. No abstract available.

PMID:
17966385
16.

The role of T-cell leukemia translocation-associated gene protein in human tumorigenesis and osteoclastogenesis.

Kotake S, Yago T, Kawamoto M, Nanke Y.

J Biomed Biotechnol. 2012;2012:675317. doi: 10.1155/2012/675317. Epub 2011 Nov 24. Review.

17.

[Hormones and osteoporosis update. Effect of angiotensin II on bone metabolism].

Nakagami H, Morishita R.

Clin Calcium. 2009 Jul;19(7):997-1002. Review. Japanese.

PMID:
19567997
18.

Calcium channels: the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis.

Park R, Ji JD.

Inflamm Res. 2016 May;65(5):347-54. doi: 10.1007/s00011-016-0920-7. Epub 2016 Feb 6. Review.

PMID:
26852086
19.

Proteomic approaches to study osteoclast biology.

Segeletz S, Hoflack B.

Proteomics. 2016 Oct;16(19):2545-2556. doi: 10.1002/pmic.201500519. Epub 2016 Aug 4. Review.

PMID:
27350065
20.

Differential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritis.

Goldring SR.

Rheumatology (Oxford). 2016 Dec;55(suppl 2):ii56-ii60. Review.

PMID:
27856661

Supplemental Content

Support Center